See the DrugPatentWatch profile for Rythmol
What’s the real name behind Rythmol?
Rythmol is a brand name for the calcium‑channel blocker nifedipine, used mainly to treat high blood pressure and angina. The active ingredient is the same in all versions of the drug, regardless of the brand name[1].
Which generics match Rythmol?
Generic nifedipine tablets and capsules are marketed by several manufacturers worldwide—Teva, Mylan, Sandoz, and others supply generic versions that contain exactly the same dose and formulation as Rythmol[2]. In the United States the FDA lists many generic equivalents; in India, the brand Rythmol is sold by Dr. Reddy’s and other Indian companies as a generic of nifedipine[3].
Are generics as effective and safe?
Because generic manufacturers must meet FDA (or equivalent) bioequivalence standards, generic nifedipine performs identically to the brand in terms of blood‑pressure lowering and angina relief. Side‑effect profiles are also comparable; the most common adverse reactions—headache, flushing, edema—are the same for both[4].
Where can you buy a generic Rythmol?
In the U.S. pharmacies, online retailers, and discount programs such as GoodRx list generic nifedipine at lower prices. Internationally, local pharmacies or online drug suppliers in the country of residence typically carry generic versions under their own brand names[5].
How much cheaper is the generic?
Generic nifedipine is usually 70–90 % cheaper than the brand Rythmol. For example, a 30‑day supply of 10 mg tablets can cost under $10 via a discount card, compared with $30–$40 for the branded version in the U.S.[5].
When did the brand patents expire?
Patents on nifedipine’s formulation and delivery system expired decades ago, allowing generic entry in most markets. In the United States, the original patent expired in 1993; the FDA approved the first generic in 1995[4]. This long‑standing generic status means new branded versions are unlikely to appear unless a new formulation (e.g., extended‑release) receives a separate patent.
Can patients switch from Rythmol to a generic safely?
The FDA recommends that switching between brand and generic nifedipine is safe when the same dose and formulation (e.g., immediate‑release) are used. Patients should inform their prescriber if they experience any new or worsening symptoms after the switch[4].
What side effects should patients watch for?
Common side effects—headache, facial flushing, swelling of the ankles, and dizziness—are shared by all nifedipine products. Rarely, patients may experience hypotension or